A long-term survival pattern for breast cancer treated in a single institution

Indian Journal of Cancer

Volumn 48, Issue 2, 2011, Pages 187-192

  Gokce, T ^a,b   Karadogan, I ^b   Akcay C ^b  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Izmir Oncology Center   (Turkey)

Author keywords

Breast carcinoma; chemotherapy; overall survival; radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT FAILURE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LOCAL FAILURE FREE SURVIVAL; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MENOPAUSE; TURKEY (REPUBLIC); BREAST TUMOR; CLINICAL TRIAL; FOLLOW UP; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; MORTALITY; PAGET NIPPLE DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855737208     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.82884     Document Type: Article

References (23)

1. Eser S, Zorlu F, Divtik RT, Cal C, Ozkan M, Kirkali Z. Incidence and epidemiological features of cancers of the genitourinary tract in Izmir between 1993-2002. Asian Pac J Cancer Prev 2009;10:491-6.
2. Gulhan I, Eser S, Yakut C, Bige O, Ilhan E, Yildirim Y, et al. Second primary gynecologic cancers after breast cancer in Turkish women. Int J Gynecol Cancer 2009;19:648-50.
3. Fidaner C, Eser SY, Parkin DM. Incidence in Izmir in 1993 and 1994: First results from Izmir Cancer Registry. Eur J Cancer 2001;37:83-92.
4. Hulka BS, Moorman PG. Breast cancer: Hormones and other risk factors. Maturitas 2008;61:203-13.
5. Demirkan B, Alacacioglu A, Yilmaz U. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma. Jpn J Clin Oncol 2007;37:256-65
6. American Cancer Society, Breast Cancer Facts and Figures 2007- 2008. Available from: Http://www.cancer.org/downloads/STT/ BCFF-Final.pdf. [cited in 2008].
7. World Cancer Report 2008, International Agency for Research on Cancer, Lyon, 2008. Available from: Http://www.iarc.fr/en/ publications/pdfs-online/wcr/ 2008/index.php. [cited in 2008].
8. Devilee P, Tavassoli FA, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003.
9. Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE. Breast cancer risk factors defined by estrogen and progesterone receptor status: The multiethnic cohort study. Am J Epidemiol 2009;169:1251-9.
10. Wood WC, Budman DR, Korzun AH, Cooper MR, Younger J, Hart RD, et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 1994;330:1253-9.
11. Muss HB, Thor AD, Berry DA, Kute T, Liu ET, Koerner F, et al. erbB-2 and response to doxorubicin in patients with axillary lymph nodepositive, hormone receptor-negative breast cancer. N Engl J Med 1994;330:1260-6.
12. Paik S, Bryant J, Park C, Fisher B, Tan-Chiu E, Hyams D, et al. erbB-2 and response to doxorubicin in patients with axillary lymph nodepositive, hormone receptor-negative breast cancer. J Natl Cancer Inst 1998;90:1361-70.
13. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002.
14. De Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L. Distinction between isolated tumour cells and micrometastases in breast cancer: Is it reliable and useful? Cancer 2008;112:1672-8.
15. Franceschini G, Terribile D, Fabbri C, Magno S, D'Alba P, Chiesa F, et al. Management of locally advanced breast cancer. Minerva Chir 2007;62:249-55.
16. Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, et al. The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumour downstaging with induction chemotherapy. Cancer 2000;88:1417-24.
17. Ries LA, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ, et al, editors. SEER Cancer Statistics Review, 1975-2005, National Cancer Institute. Bethesda, MD. Available from: Http:// seer.cancer.gov/csr/1975-2005/. [submitted on 2007 Nov 2007] [cited in 2008].
18. Sirin A, Atan SU, Tasci E. Protection from cancer and early diagnosis applications in Izmir, Turkey: A pilot study. Cancer Nurs 2006;29:207-13.
19. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: Population based study. BMJ 2000;320:474-8.
20. Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 2008;66:65-74.
21. Zhang CX, Ho SC, Chen YM, Fu JH, Cheng SZ, Lin FY. Greater vegetable and fruit intake is associated with a lower risk of breast cancer among Chinese women. Int J Cancer 2009;125:181-8.
22. Chlebowski RT, Blackburn GL, Thomson CA, Nixon DW, Shapiro A, Hoy MK, et al. Dietary fat reduction and breast cancer outcome: Interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst 2006;98:1767-76.
23. Trichopoulou A, Lagiou P, Kuper H, Trichopoulos D. Cancer and Mediterranean dietary traditions. Cancer Epidemiol Biomarkers Prev 2000;9:869-73.